149 related articles for article (PubMed ID: 17296706)
1. Radiofrequency ablation of liver metastases from breast cancer: results in 14 patients.
Gunabushanam G; Sharma S; Thulkar S; Srivastava DN; Rath GK; Julka PK; Bhatnagar S
J Vasc Interv Radiol; 2007 Jan; 18(1 Pt 1):67-72. PubMed ID: 17296706
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach".
Livraghi T; Solbiati L; Meloni F; Ierace T; Goldberg SN; Gazelle GS
Cancer; 2003 Jun; 97(12):3027-35. PubMed ID: 12784338
[TBL] [Abstract][Full Text] [Related]
3. Five-year survival following radiofrequency ablation of small, solitary, hepatic colorectal metastases.
Gillams AR; Lees WR
J Vasc Interv Radiol; 2008 May; 19(5):712-7. PubMed ID: 18440460
[TBL] [Abstract][Full Text] [Related]
4. [Radiofrequency ablation in primary and secondary liver tumors].
Carditello A; Scisca C; David A; Stilo F; Basile M
Chir Ital; 2002; 54(1):83-6. PubMed ID: 11942016
[TBL] [Abstract][Full Text] [Related]
5. Radiofrequency ablation for the management of liver tumors.
Bachar GN; Greif F; Mor E; Tur-Kaspa R; Belenky A
Isr Med Assoc J; 2003 Jul; 5(7):496-500. PubMed ID: 12901246
[TBL] [Abstract][Full Text] [Related]
6. Radiofrequency ablation of neuroendocrine liver metastases: the Middlesex experience.
Gillams A; Cassoni A; Conway G; Lees W
Abdom Imaging; 2005; 30(4):435-41. PubMed ID: 15759207
[TBL] [Abstract][Full Text] [Related]
7. [Percutaneous radiofrequency ablation of hepatic metastases. Preliminary experience].
De Baere T; Elias D; Ducreux M; Dromain C; Kuach V; Gamal El Din M; Sobotka A; Lasser P; Roche A
Gastroenterol Clin Biol; 1999 Nov; 23(11):1128-33. PubMed ID: 10651531
[TBL] [Abstract][Full Text] [Related]
8. Long-term survival after an aggressive surgical approach in patients with breast cancer hepatic metastases.
Vlastos G; Smith DL; Singletary SE; Mirza NQ; Tuttle TM; Popat RJ; Curley SA; Ellis LM; Roh MS; Vauthey JN
Ann Surg Oncol; 2004 Sep; 11(9):869-74. PubMed ID: 15342348
[TBL] [Abstract][Full Text] [Related]
9. [MRI-guided percutaneous radiofrequency ablation of hepatic neoplasms--first technical and clinical experiences].
Huppert PE; Trübenbach J; Schick F; Pereira P; König C; Claussen CD
Rofo; 2000 Aug; 172(8):692-700. PubMed ID: 11013611
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous radiofrequency ablation for inoperable non-small cell lung cancer and metastases: preliminary report.
Lee JM; Jin GY; Goldberg SN; Lee YC; Chung GH; Han YM; Lee SY; Kim CS
Radiology; 2004 Jan; 230(1):125-34. PubMed ID: 14645875
[TBL] [Abstract][Full Text] [Related]
11. Phase II feasibility study on the combination of two different regional treatment approaches in patients with colorectal "liver-only" metastases: hepatic interstitial brachytherapy plus regional chemotherapy.
Wieners G; Pech M; Hildebrandt B; Peters N; Nicolaou A; Mohnike K; Seidensticker M; Sawicki M; Wust P; Ricke J
Cardiovasc Intervent Radiol; 2009 Sep; 32(5):937-45. PubMed ID: 19472000
[TBL] [Abstract][Full Text] [Related]
12. Radiofrequency ablation of colorectal liver metastases: mid-term results in 68 patients.
Jakobs TF; Hoffmann RT; Trumm C; Reiser MF; Helmberger TK
Anticancer Res; 2006; 26(1B):671-80. PubMed ID: 16739337
[TBL] [Abstract][Full Text] [Related]
13. Two-stage surgical treatment of unresectable obstructive rectal cancer with synchronous hepatic metastases.
Tsimogiannis KE; Pappas-Gogos GK; Nikas K; Stefanaki-Nikou S; Gossios K; Tsimoyiannis EC
Am Surg; 2007 Dec; 73(12):1218-23. PubMed ID: 18186375
[TBL] [Abstract][Full Text] [Related]
14. Complications from radiofrequency ablation of liver metastases.
Zagoria RJ; Chen MY; Shen P; Levine EA
Am Surg; 2002 Feb; 68(2):204-9. PubMed ID: 11845810
[TBL] [Abstract][Full Text] [Related]
15. Radiofrequency ablation for the treatment of unresectable lung metastases in patients with colorectal cancer: a multicenter study in Japan.
Yamakado K; Hase S; Matsuoka T; Tanigawa N; Nakatsuka A; Takaki H; Takao M; Inoue Y; Kanazawa S; Inoue Y; Sawada S; Kusunoki M; Takeda K
J Vasc Interv Radiol; 2007 Mar; 18(3):393-8. PubMed ID: 17377185
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous radiofrequency ablation with a multiple-electrode switching-generator system.
Weisbrod AJ; Atwell TD; Callstrom MR; Farrell MA; Mandrekar JN; Charboneau JW
J Vasc Interv Radiol; 2007 Dec; 18(12):1528-32. PubMed ID: 18057287
[TBL] [Abstract][Full Text] [Related]
17. Surgical and ablative treatment for metastatic adenocarcinoma to the liver from unknown primary tumor.
Hawksworth J; Geisinger K; Zagoria R; Kavanagh P; Howerton R; Levine EA; Shen P
Am Surg; 2004 Jun; 70(6):512-7. PubMed ID: 15212405
[TBL] [Abstract][Full Text] [Related]
18. Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year.
de Baere T; Elias D; Dromain C; Din MG; Kuoch V; Ducreux M; Boige V; Lassau N; Marteau V; Lasser P; Roche A
AJR Am J Roentgenol; 2000 Dec; 175(6):1619-25. PubMed ID: 11090390
[TBL] [Abstract][Full Text] [Related]
19. Clinical course of breast cancer patients with metastases limited to the liver treated with chemotherapy.
Er O; Frye DK; Kau SW; Broglio K; Valero V; Hortobagyi GN; Arun B
Cancer J; 2008; 14(1):62-8. PubMed ID: 18303485
[TBL] [Abstract][Full Text] [Related]
20. The possible role of radiofrequency as complementary treatment of locally advanced gastric cancer.
Carditello A; Scisca C; Stilo F; Parisi A; Basile M
Ann Ital Chir; 2005; 76(1):39-41. PubMed ID: 16035670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
